Follow the 신일제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 신일제약 has published 54 insider filings. The latest transaction was reported on 4 June 2026 (Sale). Among the most active insiders: 홍성소. Every trade is accessible without an account.
54
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
5 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.